Genetic interaction between the m-AAA protease isoenzymes reveals novel roles in cerebellar degeneration.

The mitochondrial m-AAA protease has a crucial role in axonal development and maintenance. Human mitochondria possess two m-AAA protease isoenzymes: a hetero-oligomeric complex, composed of paraplegin and AFG3L2 (Afg3 like 2), and a homo-oligomeric AFG3L2 complex. Loss of function of paraplegin (encoded by the SPG7 gene) causes hereditary spastic paraplegia, a disease characterized by retrograde degeneration of cortical motor axons. Spg7(-/-) mice show a late-onset degeneration of long spinal and peripheral axons with accumulation of abnormal mitochondria. In contrast, Afg3l2(Emv66/Emv66) mutant mice, lacking the AFG3L2 protein, are affected by a severe neuromuscular phenotype, due to defects in motor axon development. The role of the homo-oligomeric m-AAA protease and the extent of cooperation and redundancy between the two isoenzymes in adult neurons are still unclear. Here we report an early-onset severe neurological phenotype in Spg7(-/-) Afg3l2(Emv66/+) mice, characterized by loss of balance, tremor and ataxia. Spg7(-/-) Afg3l2(Emv66/+) mice display acceleration and worsening of the axonopathy observed in paraplegin-deficient mice. In addition, they show prominent cerebellar degeneration with loss of Purkinje cells and parallel fibers, and reactive astrogliosis. Mitochondria from affected tissues are prone to lose mt-DNA and have unstable respiratory complexes. At late stages, neurons contain structural abnormal mitochondria defective in COX-SDH reaction. Our data demonstrate genetic interaction between the m-AAA isoenzymes and suggest that different neuronal populations have variable thresholds of susceptibility to reduced levels of the m-AAA protease. Moreover, they implicate impaired mitochondrial proteolysis as a novel pathway in cerebellar degeneration.

[1]  A. Paetau,et al.  Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. , 2008, Human molecular genetics.

[2]  M. Zeviani,et al.  Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice , 2008, Human molecular genetics.

[3]  C. Gellera,et al.  Spinocerebellar ataxia type 28: A novel autosomal dominant cerebellar ataxia characterized by slow progression and ophthalmoparesis , 2008, The Cerebellum.

[4]  W. Watt,et al.  Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. , 2008, Cell metabolism.

[5]  N. Bresolin,et al.  A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia , 2008, Human mutation.

[6]  J. Guénet,et al.  The Mitochondrial Protease AFG3L2 Is Essential for Axonal Development , 2008, The Journal of Neuroscience.

[7]  J. McCaffery,et al.  Mitochondrial Fusion Protects against Neurodegeneration in the Cerebellum , 2007, Cell.

[8]  E. Rugarli,et al.  Variable and Tissue-Specific Subunit Composition of Mitochondrial m-AAA Protease Complexes Linked to Hereditary Spastic Paraplegia , 2006, Molecular and Cellular Biology.

[9]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[10]  E. Rugarli,et al.  Translating m-AAA protease function in mitochondria to hereditary spastic paraplegia. , 2006, Trends in molecular medicine.

[11]  Sarah Calvo,et al.  MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion , 2006, Nature Genetics.

[12]  A. Durr,et al.  Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia , 2006, Neurology.

[13]  E. Rugarli,et al.  The m-AAA Protease Defective in Hereditary Spastic Paraplegia Controls Ribosome Assembly in Mitochondria , 2005, Cell.

[14]  M. Beal,et al.  Mitochondria take center stage in aging and neurodegeneration , 2005, Annals of neurology.

[15]  E. Rugarli,et al.  Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. , 2004, The Journal of clinical investigation.

[16]  A. Ballabio,et al.  Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia , 2003, The Journal of cell biology.

[17]  N. Henderson,et al.  Blue Native electrophoresis to study mitochondrial and other protein complexes. , 2002, Methods.

[18]  G. Sutherland,et al.  Molecular and functional analyses of the human and mouse genes encoding AFG3L1, a mitochondrial metalloprotease homologous to the human spastic paraplegia protein. , 2001, Genomics.

[19]  N. Romero,et al.  Late-onset mitochondrial DNA depletion: DNA copy number, multiple deletions, and compensation. , 2001 .

[20]  A. Consiglio,et al.  In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice , 2001, Nature Medicine.

[21]  M. Filbin,et al.  Epitope-Tagged P0Glycoprotein Causes Charcot-Marie-Tooth–Like Neuropathy in Transgenic Mice , 2000, The Journal of cell biology.

[22]  Sergio Cocozza,et al.  Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease , 1998, Cell.

[23]  M. Tiveron,et al.  The Expression Pattern of the Transcription Factor Phox2 Delineates Synaptic Pathways of the Autonomic Nervous System , 1996, The Journal of Neuroscience.

[24]  G. Rouleau,et al.  Hereditary spastic paraplegia , 2006, Current neurology and neuroscience reports.

[25]  C. Sotelo,et al.  Early dendritic development of Purkinje cells in the rat cerebellum. A light and electron microscopic study using axonal tracing in 'in vitro' slices. , 1991, Brain research. Developmental brain research.

[26]  D. Wallace,et al.  Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies. , 1990, Biochimica et biophysica acta.

[27]  A. Harding.  CLASSIFICATION OF THE HEREDITARY ATAXIAS AND PARAPLEGIAS , 1983, The Lancet.

[28]  Marco Seri,et al.  SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11.2. , 2006, Brain : a journal of neurology.

[29]  C. Gellera,et al.  SCA 28 , a novel form of autosomal dominant cerebellar ataxia on chromosome 18 p 11 . 22 – q 11 . 2 , 2005 .

[30]  Massimo Pandolfo,et al.  The Cerebellum and its Disorders: SPORADIC DISEASES , 2001 .